Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
1994 1
1995 2
1996 5
1997 5
1998 6
1999 8
2000 11
2001 10
2002 12
2003 11
2004 16
2005 17
2006 15
2007 15
2008 16
2009 11
2010 16
2011 28
2012 45
2013 51
2014 80
2015 69
2016 55
2017 79
2018 54
2019 84
2020 85
2021 106
2022 96
2023 101
2024 60

Text availability

Article attribute

Article type

Publication date

Search Results

1,029 results

Results by year

Filters applied: . Clear all
Page 1
Soluble Urokinase Plasminogen Activator Receptor (suPAR) as a Biomarker of Systemic Chronic Inflammation.
Rasmussen LJH, Petersen JEV, Eugen-Olsen J. Rasmussen LJH, et al. Front Immunol. 2021 Dec 2;12:780641. doi: 10.3389/fimmu.2021.780641. eCollection 2021. Front Immunol. 2021. PMID: 34925360 Free PMC article. Review.
In this review, we highlight 10 properties and characteristics that are shared by the blood protein soluble urokinase plasminogen activator receptor (suPAR) and SCI, supporting the argument that suPAR is a biomarker of SCI: (1) Expression and release of suPAR
In this review, we highlight 10 properties and characteristics that are shared by the blood protein soluble urokinase plasminogen activator …
suPAR: An Inflammatory Mediator for Kidneys.
Sudhini YR, Wei C, Reiser J. Sudhini YR, et al. Kidney Dis (Basel). 2022 Jun 8;8(4):265-274. doi: 10.1159/000524965. eCollection 2022 Jul. Kidney Dis (Basel). 2022. PMID: 35949208 Free PMC article. Review.
Moreover, the implication of circulating suPAR levels in kidney transplantation and plasmapheresis not only indicates its relevance in monitoring for recurrence but also implies suPAR as a possible therapeutic target. ...KEY MESSAGES: The last 10 years of research h …
Moreover, the implication of circulating suPAR levels in kidney transplantation and plasmapheresis not only indicates its relevance i …
suPAR in cardiovascular disease.
Montecillo J, Pirker T, Pemberton C, Chew-Harris J. Montecillo J, et al. Adv Clin Chem. 2024;121:89-131. doi: 10.1016/bs.acc.2024.04.005. Epub 2024 Apr 25. Adv Clin Chem. 2024. PMID: 38797545 Review.
Studies have assessed the correlation between suPAR in cardiovascular disease (CVD). It is postulated that suPAR may serve as an indicator of inflammatory activation and burden during CVD progression. ...Whilst the involvement of suPAR has been explored in ot …
Studies have assessed the correlation between suPAR in cardiovascular disease (CVD). It is postulated that suPAR may serve as …
suPAR, a Circulating Kidney Disease Factor.
Wei C, Spear R, Hahm E, Reiser J. Wei C, et al. Front Med (Lausanne). 2021 Oct 6;8:745838. doi: 10.3389/fmed.2021.745838. eCollection 2021. Front Med (Lausanne). 2021. PMID: 34692736 Free PMC article. Review.
Release of the receptor results in variable levels of soluble uPAR (suPAR) in the blood circulation. suPAR levels have been linked to many disease states. In this mini-review, we discuss suPAR as a key circulating molecule mediating kidney disease with a part …
Release of the receptor results in variable levels of soluble uPAR (suPAR) in the blood circulation. suPAR levels have been li …
suPAR and chronic kidney disease-a podocyte story.
Zeier M, Reiser J. Zeier M, et al. Pflugers Arch. 2017 Aug;469(7-8):1017-1020. doi: 10.1007/s00424-017-2026-7. Epub 2017 Jul 8. Pflugers Arch. 2017. PMID: 28689240 Review.
Elevated levels of suPAR have been linked to the pathogenesis of the kidney disease focal and segmental glomerulosclerosis. Here, suPAR acts on podocytes by activating alphavbeta3 integrins. Large observational studies showed that suPAR also predicts chronic …
Elevated levels of suPAR have been linked to the pathogenesis of the kidney disease focal and segmental glomerulosclerosis. Here, …
SuPAR, an emerging biomarker in kidney and inflammatory diseases.
Hamie L, Daoud G, Nemer G, Nammour T, El Chediak A, Uthman IW, Kibbi AG, Eid A, Kurban M. Hamie L, et al. Postgrad Med J. 2018 Sep;94(1115):517-524. doi: 10.1136/postgradmedj-2018-135839. Epub 2018 Sep 3. Postgrad Med J. 2018. PMID: 30177549 Review.
Soluble urokinase plasminogen activator receptor (suPAR) is a circulating form of a physiological and pathophysiological important cell surface receptor, implicated in inflammation. Recent studies showed that suPAR is a promising biomarker, useful for diagnosis, ass …
Soluble urokinase plasminogen activator receptor (suPAR) is a circulating form of a physiological and pathophysiological important ce …
suPAR links a dysregulated immune response to tissue inflammation and sepsis-induced acute kidney injury.
Nusshag C, Wei C, Hahm E, Hayek SS, Li J, Samelko B, Rupp C, Szudarek R, Speer C, Kälble F, Schaier M, Uhle F, Schmitt FC, Fiedler MO, Krautkrämer E, Cao Y, Rodriguez R, Merle U, Eugen-Olsen J, Zeier M, Weigand MA, Morath C, Brenner T, Reiser J. Nusshag C, et al. JCI Insight. 2023 Apr 10;8(7):e165740. doi: 10.1172/jci.insight.165740. JCI Insight. 2023. PMID: 37036003 Free PMC article.
The pathophysiologic relevance of varying suPAR levels in SI-AKI was explored in a polymicrobial sepsis model in WT, (s)uPAR-knockout, and transgenic suPAR-overexpressing mice. ...Hence, suPAR allows for an innate immune-derived and kidney function-independen …
The pathophysiologic relevance of varying suPAR levels in SI-AKI was explored in a polymicrobial sepsis model in WT, (s)uPAR-knockout …
Predictive value of suPAR in AKI: a systematic review and meta-analysis.
Huang Y, Huang S, Zhuo X, Lin M. Huang Y, et al. Clin Exp Nephrol. 2023 Jan;27(1):1-11. doi: 10.1007/s10157-022-02300-2. Epub 2022 Dec 5. Clin Exp Nephrol. 2023. PMID: 36469196 Free PMC article. Review.
Therefore, we conducted this systematic review and meta-analysis to evaluate the predictive value of suPAR for AKI. METHODS: Pubmed, EMBASE, Cochrane Library, and Web of Science databases were searched until December 2021 to obtain the literature on the prediction of su
Therefore, we conducted this systematic review and meta-analysis to evaluate the predictive value of suPAR for AKI. METHODS: Pubmed, …
suPAR: A New Biomarker for Cardiovascular Disease?
Hodges GW, Bang CN, Wachtell K, Eugen-Olsen J, Jeppesen JL. Hodges GW, et al. Can J Cardiol. 2015 Oct;31(10):1293-302. doi: 10.1016/j.cjca.2015.03.023. Epub 2015 Mar 25. Can J Cardiol. 2015. PMID: 26118447 Review.
Furthermore, of particular interest is the suggestion that suPAR reflects a pathophysiological pathway more closely linked with subclinical organ damage than CRP. We provide the first comprehensive review of suPAR in CVD and explore its function and usefulness in pr …
Furthermore, of particular interest is the suggestion that suPAR reflects a pathophysiological pathway more closely linked with subcl …
suPAR: the molecular crystal ball.
Thunø M, Macho B, Eugen-Olsen J. Thunø M, et al. Dis Markers. 2009;27(3):157-72. doi: 10.3233/DMA-2009-0657. Dis Markers. 2009. PMID: 19893210 Free PMC article. Review.
soluble urokinase Plasminogen Activator Receptor (suPAR) levels reflect inflammation and elevated suPAR levels are found in several infectious diseases and cancer. suPAR exists in three forms; suPAR(I-III), suPAR(II-III) and suPAR(I) whic …
soluble urokinase Plasminogen Activator Receptor (suPAR) levels reflect inflammation and elevated suPAR levels are found in se …
1,029 results